Bank Of America Corp Landos Biopharma, Inc. Transaction History

Bank Of America Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.26 - $0.55 $6 - $14	26 New	26 $0
Q3 2022 Nov 14, 2022	SELL	$0.67 - $1.26 $15,944 - $29,985	-23,798 Reduced 59.08%	16,482 $11,000
Q2 2022 Aug 12, 2022	SELL	$0.6 - $1.5 $9,624 - $24,061	-16,041 Reduced 28.48%	40,280 $29,000
Q1 2022 May 16, 2022	BUY	$1.44 - $5.22 $36,138 - $131,001	25,096 Added 80.37%	56,321 $83,000
Q4 2021 Feb 08, 2022	BUY	$4.7 - $15.0 $139,773 - $446,085	29,739 Added 2001.28%	31,225 $150,000
Q3 2021 Nov 15, 2021	SELL	$9.77 - $15.77 $95,130 - $153,552	-9,737 Reduced 86.76%	1,486 $22,000
Q2 2021 Sep 13, 2021	BUY	$9.26 - $12.53 $103,924 - $140,624	11,223 New	11,223 $130,000

Ticker LABP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,254,900
Description
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of u...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.